• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Pain Therapeutics Inc. (PTIE)

    -NasdaqGS
    2.01 Down 0.02(0.99%) 4:00PM EST
    |After Hours : 2.01 0.00 (0.00%) 4:50PM EST
    Add to Portfolio
    Prev Close:2.03
    Open:2.01
    Bid:N/A
    Ask:2.20 x 400
    1y Target Est:8.00
    Beta:2.6
    Next Earnings Date:N/A
    Day's Range:1.91 - 2.03
    52wk Range:1.61 - 6.22
    Volume:67,017
    Avg Vol (3m):265,552
    Market Cap:91.97M
    P/E (ttm):3.99
    EPS (ttm):0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PTIEDown 0.99%91.97M
    ABTDown 1.06%65.77B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.30
    Quarterly EPS Est (Mar-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs. Its lead drug candidate is REMOXY (oxycodone) Extended-Release Capsules CII, an investigational drug with a controlled release formulation of oxycodone for patients with m... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback